{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361418518953319040.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.2165/00003088-199019050-00003"}}],"dc:title":[{"@value":"Clinical Pharmacokinetics of Interferons"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381418518953319040","@type":"Researcher","foaf:name":[{"@value":"Robert J. Wills"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03125963"}],"prism:publicationName":[{"@value":"Clinical Pharmacokinetics"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"1990-11","prism:volume":"19","prism:number":"5","prism:startingPage":"390","prism:endingPage":"399"},"reviewed":"false","createdAt":"2007-12-05","modifiedAt":"2013-01-20","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050282810771096064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Long-term elimination of hepatitis C virus from human hepatocyte chimeric mice after interferon-γ gene transfer."}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185477366784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Guidelines for the Management of Hepatitis <scp>C</scp> Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661764157312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204286583296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Relationship Between 24-Hour Rhythm in Antiviral Effect of Interferon-.BETA. and Interferon-.ALPHA./.BETA. Receptor Expression in Mice."},{"@value":"Relationship Between 24-Hour Rhythm in Antiviral Effect of Interferon-β and Interferon-α/β Receptor Expression in Mice"},{"@language":"ja-Kana","@value":"Relationship Between 24 Hour Rhythm in Antiviral Effect of Interferon ベータ and Interferon アルファ ベータ Receptor Expression in Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205179717376","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Co-administration of Tacrolimus Suppresses Pharmacokinetic Modulation of Multiple Subcutaneously Administered Human Interferon-alpha in Beagle Dogs"}]},{"@id":"https://cir.nii.ac.jp/crid/1390005667263489664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771529088","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Treatment Guidelines of Hepatitis C"},{"@language":"ja","@value":"C型肝炎治療ガイドライン（第1版）"},{"@language":"ja-Kana","@value":"Cガタ カンエン チリョウ ガイドライン(ダイ1ハン)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681407428224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pharmacokinetic studies of the recombinant chicken interferon-α in broiler          chickens"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.2165/00003088-199019050-00003"},{"@type":"CROSSREF","@value":"10.2133/dmpk.25.149_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"},{"@type":"CROSSREF","@value":"10.1111/hepr.12020_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"},{"@type":"CROSSREF","@value":"10.1292/jvms.15-0681_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"},{"@type":"CROSSREF","@value":"10.1186/s12985-015-0412-3_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"},{"@type":"CROSSREF","@value":"10.2957/kanzo.53.355_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"},{"@type":"CROSSREF","@value":"10.1254/jjp.90.304_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"},{"@type":"CROSSREF","@value":"10.1089/humc.2013.066_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.5432-20_references_DOI_159ND8L2Hs1AxS0zC9lY8eu8dn6"}]}